Author | Tian Zhang, MD | OncLive

Author | Tian Zhang, MD

Articles

Dr. Zhang on the IMvigor130 Trial in Metastatic Urothelial Cancer

October 12, 2019

Video

Tian Zhang, MD, discusses data from the randomized phase III IMvigor130 trial, which compared the safety and efficacy of atezolizumab in combination with platinum-based chemotherapy, atezolizumab monotherapy, and chemotherapy alone, in the frontline treatment of patients with metastatic urothelial cancer.

Dr. Zhang Discusses Neoadjuvant Therapy in Kidney Cancer

January 25, 2018

Video

Tian Zhang, MD, assistant professor of medicine, Duke University School of Medicine, Duke Cancer Institute, discusses neoadjuvant therapy in kidney cancer.

Dr. Zhang on Toxicities of Treatments in RCC

January 09, 2018

Video

Tian Zhang, MD, assistant professor of medicine, Duke University School of Medicine, Duke Cancer Institute, discusses the tolerability of agents used for the treatment of patients with renal cell carcinoma (RCC).

Dr. Zhang on the Importance of Adjuvant Clinical Trials in RCC

January 03, 2018

Video

Tian Zhang, MD, assistant professor of medicine, Duke University School of Medicine, Duke Cancer Institute, discusses the importance of clinical trials in the adjuvant setting of renal cell carcinoma.

x